Tag: EpiPen
Sanofi May Take Mylan To Court Again Over EpiPen Antitrust Woes
Sanofi has long argued that generics giant Mylan used anticompetitive practices to market its popular epinephrine autoinjector EpiPen, specifically scuppering the launch of its...
Mylan Defeats Sanofi’s EpiPen Antitrust Suit
Mylan has dodged claims that it unlawfully shielded its EpiPen from competition by driving Sanofi’s epinephrine auto-injector from the market through exclusive agreements with insurers and...
Mylan Loses Bid To dismiss EpiPen Antitrust Suit
Mylan and a group of pharmacy benefit managers have lost a bid to dismiss a class action claiming the drugmaker paid kickbacks to the...
Antitrust EpiPen MDL Case Given Partly Class Status
Part of the multidistrict lawsuit over EpiPen price gouging, which involves racketeering and antitrust claims against Mylan NV, was certified as a class action...
US: Sanofi seeks billions in EpiPen antitrust suit
Sanofi wants Mylan to pay up to US$11.7 billion in damages for engaging in a scheme to squelch competition to its EpiPen allergy treatment,...
US: EpiPen makers must face antitrust claims, judge rules
A Kansas district court judge has dismissed motions by Mylan, Pfizer, and others to dismiss class action complaints accusing them of RICO Act violations,...
US: Mylan reaches EpiPen Settlment for $465m
On August 17, Mylan and federal investigators finalized a US$465 million settlement of charges the drugmaker overcharged the government for the injection allergy medication...
US: EpiPen maker may have overcharged taxpayers by $1.27 billion
Mylan Pharmaceuticals, the maker of EpiPens for allergy sufferers, may have overcharged taxpayers as much as $1.27 billion by misclassifying their life-saving devices under...
US: Noted antitrust attorney to lead nationwide class action suit over...
A federal judge in Kansas has appointed Dallas lawyer Warren T. Burns and two other attorneys to lead a nationwide class action against Mylan...
